Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
Authors
Keywords
Effectiveness, HbA1c, Hypoglycemia, Liraglutide, Literature review, Real-world evidence, Safety, Type 2 diabetes, Weight
Journal
Diabetes Therapy
Volume 7, Issue 3, Pages 411-438
Publisher
Springer Nature
Online
2016-06-27
DOI
10.1007/s13300-016-0180-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial
- (2016) Yutaka Seino et al. Journal of Diabetes Investigation
- Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study
- (2015) Erin K. Buysman et al. ADVANCES IN THERAPY
- Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study
- (2015) Jean-Francois Gautier et al. ADVANCES IN THERAPY
- Correlation Between Baseline Characteristics and Clinical Outcomes in a Large Population of Diabetes Patients Treated with Liraglutide in a Real-World Setting in Italy
- (2015) Annunziata Lapolla et al. CLINICAL THERAPEUTICS
- Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy
- (2015) Eusebio Chiefari et al. Diabetes Technology & Therapeutics
- Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes
- (2015) Reimar W. Thomsen et al. DIABETOLOGIA
- Early liraglutide treatment improves β-cell function in patients with type 2 diabetes: a retrospective cohort study
- (2015) Yoshinobu Kondo et al. ENDOCRINE JOURNAL
- An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes
- (2015) Fernando Gomez-Peralta et al. BMC Endocrine Disorders
- Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52-week, open-label, parallel-group trial
- (2015) Kohei Kaku et al. Journal of Diabetes Investigation
- Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
- (2015) Hideaki Jinnouchi et al. Journal of Diabetes Research
- Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case–control study
- (2015) M. Rigato et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study
- (2015) Pedro Mezquita-Raya et al. Diabetes Therapy
- Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study
- (2015) Pedro Mezquita-Raya et al. Diabetes Therapy
- Clinical efficacy of bariatric surgery versus liraglutide in patients with type 2 diabetes and severe obesity: a 12-month retrospective evaluation
- (2014) M. Cotugno et al. ACTA DIABETOLOGICA
- Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide
- (2014) Mitch DeKoven et al. ADVANCES IN THERAPY
- Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study
- (2014) Abhishek S. Chitnis et al. ADVANCES IN THERAPY
- Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
- (2014) Manfredi Rizzo et al. Cardiovascular Diabetology
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Predictors of response to liraglutide in Japanese type 2 diabetes
- (2014) Masao Toyoda et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: A prospective study
- (2014) Gonzalo Díaz-Soto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Evaluation of the effectiveness of liraglutide and sitagliptin in type 2 diabetes: a retrospective study in UK primary care
- (2014) M. E. Nyeland et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
- (2014) Kathleen M Dungan et al. LANCET
- Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study
- (2014) Kana Inoue et al. Diabetology & Metabolic Syndrome
- Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients
- (2014) G. T. Russo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
- (2014) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Efficacy of Liraglutide in a Real-Life Cohort
- (2014) Anthony Heymann et al. Diabetes Therapy
- Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States
- (2014) Qian Li et al. Diabetes Therapy
- Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients
- (2013) Gian Paolo Fadini et al. ACTA DIABETOLOGICA
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs
- (2013) D. Funch et al. DIABETES OBESITY & METABOLISM
- The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study
- (2013) K. Y. Thong et al. DIABETIC MEDICINE
- Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control
- (2013) Helena Rodbard et al. Endocrine Practice
- Real Life Effects of Liraglutide Supports Those Shown in RCTs
- (2013) A. Karasik et al. VALUE IN HEALTH
- Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function
- (2013) Ryota Usui et al. Journal of Diabetes Investigation
- Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes
- (2013) Yoshinobu Kondo et al. Journal of Diabetes Investigation
- A Retrospective Audit of Type 2 Diabetes Patients Prescribed Liraglutide in Real-Life Clinical Practice
- (2013) Ciara M. Mulligan et al. Diabetes Therapy
- Efficacy and Safety of Switching From the DPP-4 Inhibitor Sitagliptin to the Human GLP-1 Analog Liraglutide After 52 Weeks in Metformin-Treated Patients With Type 2 Diabetes: A randomized, open-label trial
- (2012) R. E. Pratley et al. DIABETES CARE
- Standards of Medical Care in Diabetes--2013
- (2012) DIABETES CARE
- Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study
- (2012) T. Ahern et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
- (2012) John B Buse et al. LANCET
- The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
- (2012) Takamasa Ohki et al. TheScientificWorldJOURNAL
- A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice
- (2012) Marc Evans et al. Diabetes Therapy
- Liraglutide Narrows the Range of Circadian Glycemic Variations in Japanese Type 2 Diabetes Patients and Nearly Flattens These Variations in Drug-Naive Type 2 Diabetes Patients: A Continuous Glucose Monitoring–Based Study
- (2011) Yutaka Mori et al. Diabetes Technology & Therapeutics
- Clinical Use of Liraglutide in Type 2 Diabetes and its Effects on Cardiovascular Risk Factors
- (2011) Ajay Varanasi et al. Endocrine Practice
- One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial
- (2011) R. Pratley et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
- (2010) J. B. Buse et al. DIABETES CARE
- Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes
- (2010) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
- (2010) Richard E Pratley et al. LANCET
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- (2009) M. Marre et al. DIABETIC MEDICINE
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
- (2008) M. Nauck et al. DIABETES CARE
- Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
- (2008) Alan Garber et al. LANCET
- Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
- (2008) W Todd Cade PHYSICAL THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started